Your browser doesn't support javascript.
loading
An Open Label Phase Ib Dose Escalation Study of TRC105 (Anti-Endoglin Antibody) with Axitinib in Patients with Metastatic Renal Cell Carcinoma.
Choueiri, Toni K; Michaelson, M Dror; Posadas, Edwin M; Sonpavde, Guru P; McDermott, David F; Nixon, Andrew B; Liu, Yingmiao; Yuan, Zhenhua; Seon, Ben K; Walsh, Meghara; Jivani, Manoj A; Adams, Bonne J; Theuer, Charles P.
Afiliação
  • Choueiri TK; Dana-Farber Cancer Institute, Boston, Massachusetts, USA toni_choueiri@dfci.harvard.edu.
  • Michaelson MD; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Posadas EM; Cedars Sinai Medical Center, Los Angeles, California, USA.
  • Sonpavde GP; University of Alabama Comprehensive Cancer Center, Birmingham, Alabama, USA.
  • McDermott DF; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Nixon AB; Duke University Medical Center, Durham, North Carolina, USA.
  • Liu Y; Duke University Medical Center, Durham, North Carolina, USA.
  • Yuan Z; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Seon BK; Roswell Park Cancer Institute, Buffalo, New York, USA.
  • Walsh M; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Jivani MA; TRACON Pharmaceuticals, Inc., San Diego, California, USA.
  • Adams BJ; TRACON Pharmaceuticals, Inc., San Diego, California, USA.
  • Theuer CP; TRACON Pharmaceuticals, Inc., San Diego, California, USA.
Oncologist ; 24(2): 202-210, 2019 02.
Article em En | MEDLINE | ID: mdl-30190302
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Axitinibe / Neoplasias Renais / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Axitinibe / Neoplasias Renais / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article